Kenneth Hoberman
2012
In 2012, Kenneth Hoberman earned a total compensation of $283.3K as Chief Operating Officer at Stemline Therapeutics.
Compensation breakdown
| Salary | $283,333 |
|---|---|
| Total | $283,333 |
Hoberman received $283.3K in salary, accounting for 100% of the total pay in 2012.
Rankings
In 2012, Kenneth Hoberman's compensation ranked 10,260th out of 11,487 executives tracked by ExecPay. In other words, Hoberman earned more than 10.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,260 out of 11,487 | 11th |
Division Manufacturing | 3,809 out of 4,253 | 10th |
Major group Chemicals And Allied Products | 1,061 out of 1,198 | 11th |
Industry group Drugs | 811 out of 920 | 12th |
Industry Pharmaceutical Preparations | 622 out of 700 | 11th |
Source: SEC filing on April 30, 2015.
Hoberman's colleagues
We found four more compensation records of executives who worked with Kenneth Hoberman at Stemline Therapeutics in 2012.